Immunotherapies for advanced hepatocellular carcinoma
Primary liver cancer is the second leading cause of tumor-related deaths in China, with hepatocellular carcinoma (HCC) accounting for 80%-90% of these. Since there is a lack of symptoms in the early stages of HCC, a large proportion of patients were identified with unresectable HCC when diagnosed. D...
Saved in:
Main Authors: | Li-Yang Sun (Author), Kang-Jun Zhang (Author), Ya-Ming Xie (Author), Jun-Wei Liu (Author), Zun-Qiang Xiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complications of immunotherapy in advanced hepatocellular carcinoma
by: Young-Gi Song, et al.
Published: (2024) -
A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
by: Yu Rim Lee
Published: (2023) -
Immunotherapy in Hepatocellular Carcinoma
Published: (2023) -
Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
by: Huang Ao, et al.
Published: (2021) -
Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma
by: Wangrui Liu, et al.
Published: (2022)